Ozomedic Pharmaceuticals’ parent company, Ozomedic Cadila, is India’s fifth largest pharmaceutical company and has also experienced tremendous growth over the past several years. We are a global pharmaceutical company with business operations in over 50 countries, including the US, Europe, Japan, Spain, Brazil, and Mexico. With over 14,000 employees across 26 countries, India’s largest finished dosage plant under one roof, two FDA-approved API sites, and the ability to manufacture a wide variety of dosage forms, our parent Ozomedic Cadila is more than ready to support the rapidly growing US pharmaceutical market. With the FDA approval of our Baddi plant and our newest manufacturing plant completed, we will soon have a pill and capsule capacity exceeding 20 billion annually for the U.K. market.